Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Students listened intently to a panel of scientists and presented their own research in a ribbiting event Thursday morning ...

Our latest posters, at the world's most prestigious gene therapy event, provide critical insights into the safety and efficacy of rAAV-based therapeutics. We support biopharma companies with ...

Poster presentation to demonstrate EBT-107's potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functiona ...

Midwestern states comprised a significant portion of attendees at the conference, with Universities from Kansas, Missouri, ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today presents IND- and CTA-enabling data for its lead clinical program, ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity financing and announced additional milestones since the start of ...

National Junior Science and Humanities Symposium, or JSHS, concluded following a five-day event April 22-26, 2025, in Chantilly, ...

The AUS portion of the event featured a high-level panel, research papers and keynotes examining AI integration across ...

First of several clinical updates through mid-2026 accepted for presentation at the 2025 American Society of Clinical Oncology Annual Meeting, with recruitment progressing for all three of our clinica ...